MM residents can now consult doctors via phone call for free | Inquirer News

MM residents can now consult doctors via phone call for free

By: - Reporter / @DYGalvezINQ
/ 10:48 AM April 07, 2020

MANILA, Philippines — Residents in Metro Manila can now get 24/7 consultation from medical professionals in the safety of their own homes.

The Department of Health (DOH) on Tuesday said that individuals in the metropolis can call the 24/7 telemedicine hotline at 02-8424-1724 to consult with a doctor for medical advice on the coronavirus disease (COVID-19) and non-COVID-19 health-related concerns.

This type of service will be free of charge.

Article continues after this advertisement

The health department said it has partnered with Telimed Management Inc. and Medgate to provide free telemedicine consultations to patients with medical concerns, COVID-19 or non-COVID-19-related.

It earlier launched the COVID-19 hotlines: 02-894-COVID (02-894-2643 ) and 1555.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, coronavirus Philippines, COVID-19, DoH, Hotline, NcoV, telemedicine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.